HomeSlots › Slot Machine 2
BGaming

Slot Machine 2 Slot Review

★★★★★ 4.7 / 5 — our rating
ESReviewed by Elin Sundqvist, Casino Analyst · Updated 13 Aug 2026
RTP
97%
Volatility
Low
Max Win
Provider
BGaming

A 97.0% RTP is the headline number here, sitting a full point above the usual 96% baseline. BGaming pairs it with low-to-medium volatility, so wins land frequently at moderate sizes rather than in rare spikes. That profile favors extended sessions on a set bankroll, where steady returns outweigh chasing a top-end payout.

How Slot Machine 2 plays

Slot Machine 2 sits at the calmer end of the variance scale. Wins land often and the swings stay shallow, so it's an easy game to settle into for a longer session without watching the balance whipsaw.

Is 97.0% a good RTP?

At 97.0%, Slot Machine 2 returns noticeably more than the ~96% industry average. Over a long run that edge matters, and it's a genuine mark in the game's favour. Bear in mind RTP is a long-run theoretical figure, not a promise for any single session.

Who should play it

Slot Machine 2 suits value-focused and casual players — a low-drama game where a solid RTP and gentle variance let a bankroll stretch across a long, relaxed session.

What we liked

  • Above-average 97.0% RTP
  • Frequent, steadier wins (low volatility)
  • From BGaming, a studio we rate

Worth knowing

  • Low-volatility play: won't suit players chasing one big hit
  • Bonus features can be slow to trigger

Want to try Slot Machine 2 in demo or real-money mode?

Play at Casumo →

Frequently asked questions

What is the RTP of Slot Machine 2?
Slot Machine 2 has a published return-to-player (RTP) of 97.0%.
What is the volatility of Slot Machine 2?
Slot Machine 2 is a low-volatility slot, meaning frequent, steadier wins.
Who makes Slot Machine 2?
Slot Machine 2 is developed by BGaming.

How we review: we verify each game's RTP, volatility and maximum win against provider data, then assess variance, features and value. Ratings reflect our editorial judgement, not commercial arrangements. Read our full methodology →